©The Author(s) 2026.
World J Gastrointest Endosc. Feb 16, 2026; 18(2): 113762
Published online Feb 16, 2026. doi: 10.4253/wjge.v18.i2.113762
Published online Feb 16, 2026. doi: 10.4253/wjge.v18.i2.113762
Table 3 Subgroup analysis of clinical outcome
| Patient with HBI < 5 (n = 28) | Patient with HBI ≥ 5 (n = 19) | |||||
| Non-preparation group (n = 9) | Preparation group | P value | Non-preparation group (n = 11) | Preparation group (n = 8) | P value | |
| Complete SBCE | 100 (9/9) | 94.7 (18/19) | 1 | 81.8 (9/11) | 87.5 (7/8) | 1 |
| Lesion detection rate | 100 (9/9) | 100 (18/18) | 1 | 88.9 (8/9) | 85.7 (6/7) | 1 |
| Gastric transit time (minutes), median (IQR) | 99 (32-141) | 50 (31-74) | 0.28 | 103 (23-194) | 58 (49-74) | 0.79 |
| Small bowel transit time (minutes), median (IQR) | 236 (168-254) | 278 (171-345) | 0.4 | 234 (213-384) | 215 (191-261) | 0.54 |
| Visibility score, median (IQR) | 3.2 (2.9-3.6) | 2.8 (2.4-3.2) | 0.15 | 2.6 (2.5-3.3) | 2.6 (2.3-3.0) | 0.73 |
- Citation: Terashi S, Ozaka S, Kagoshima Y, Shimomori Y, Takahashi H, Minezaki D, Tsutsumi K, Fukuda M, Hirashita Y, Fukuda K, Ogawa R, Kodama M, Murakami K, Mizukami K. Bowel preparation for small bowel capsule endoscopy in patients with suspected or established Crohn’s disease. World J Gastrointest Endosc 2026; 18(2): 113762
- URL: https://www.wjgnet.com/1948-5190/full/v18/i2/113762.htm
- DOI: https://dx.doi.org/10.4253/wjge.v18.i2.113762